Latest News

US FDA grants Breakthrough Therapy Designation for combination immunotherapy in HCC...

Roche has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq (atezolizumab) in combination with Avastin (bevacizumab)...



Deficiencies in operator behaviour: Premature atypical malignancies in high-volume operators

In this article, Bijan Modarai outlines recent research on the effects on radiation exposure in high-volume interventionists, why a future with alternative modalities to X-ray guided...
Augmented reality

Augmented reality can lend you the “eyes of the first operator”

In February 2018, the first European case of endovascular aneurysm repair (EVAR) for the treatment of an abdominal aortic aneurysm was performed using a prototype device...


This content is for distribution within USA only. The Direxion™ Microcatheter, with its unique shaft design, offers you unrivaled torqueability for improved maneuverability. Further enhancing your ability to access challenging treatment sites are a variety of tip shapes that allow...

Stephen B Solomon

Robert Morgan

Andrew Holden

Andrew Holden

(Visited 21,852 times, 40 visits today)